[1]
“Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Axillary Hyperhidrosis”, J of Skin, vol. 1, no. 3.1, p. s95, Oct. 2017, doi: 10.25251/skin.1.supp.94.